Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Bristol-Myers Squibb (BMS) building

NICE ‘no’ for Opdivo in kidney cancer

BMS oncology drug knocked-back in draft guidance

Novartis plots digital transformation in medical education

Outlines benefits of greater use of technology, including transparency and reach

Acorda Therapeutics appoints chief medical officer

Interim CMO Dr Burkhard Blank takes on the post in a permanent capacity

- PMLiVE

Amgen’s Kyprolis wins new indication in Europe

Regulators have handed the treatment a less restrictive licence in multiple myeloma 

- PMLiVE

Omnicom launches new DDB Health network

Will include its AgencyRx, Flashpoint, Synergy and DDB Health agencies

- PMLiVE

Novo’s world-leading insulin plant to get even bigger

Danish firm invests €54m in Kalundborg expansion

- PMLiVE

LEO Pharma picks up AZ skin disease drugs in $1bn deal

Gains rights to eczema and psoriasis treatments

- PMLiVE

US cuts at Boehringer hit sales force hardest

And Arena Pharmaceuticals plans US and Swiss 'reductions'

- PMLiVE

LaingBuisson names chairman and CEO

Former Health Secretary Stephen Dorrell and Henry Elphick join

- PMLiVE

Having it all: Women in wealthy countries consider what makes them happy

Money doesn’t buy happiness, but it is an important factor - both directly, by providing material comforts, and indirectly, by supporting an active approach to managing health and fitnessDoes wealth...

- PMLiVE

Digital influencer marketing

How good stories can drive value for brands, products and companies

- PMLiVE

AZ, BMS and Boehringer among UK Prix Galien finalists

They join Alexion, Chiesi, Janssen, Novartis, Otsuka and Takeda

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links